Fibrosing colonopathy in a man with cystic fibrosis on pancreatic enzyme supplements.

8. Spechler S. Barrett’s esophagus. N Engl J Med 2002;346:83641. 9. Devesa S, Blot W, Fraumeni J. Changing patterns in the incidence of gastric carcinoma in the United States. Cancer 1998;83:2049-53. 10. Abe Y, Ohara S, Koike T, Sekine S, Iijima K, Kawamura M, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s esophagus in Japan. Am J Gastroenterol 2004;99:1213-21. 11. Kahrilas P, Pandolfino J. Gastroesophageal reflux disease and its complications, including Barrett’s metaplasia. In: Feldman M, Friedman L, Sleisenger M, Eds. Gastrointestinal and Liver Disease, 7th ed. Philadelphia: Saunders. 2002: p. 599-622. 12. Massarrat S, Saberi-firoozi M, Soleimani A, Himmelmann GW, Hitzgez M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7:427-33. 13. Malekzadeh R, Sotoudeh M, Derakhshan M, Mikaeli J, Yazdanbod A, Yoonessi A, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the North-West of Iran. J Clin Pathol 2004;57:37-42. 14. Lundell LR, Dent J, Bennett JR. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of Los Angeles classification.Gut 1999;45:172. 15. Day DW. Esophagitis. In: Morson BC, Ed. Morson and Dawson Gastrointestinal Pathology, 4th ed. Oxford: Blackwell. 2003: p. 38-58. 16. Demeester SR, Demeester TR. The diagnosis and management of Barrett’s esophagus. Adv Surg 1999;33:29-68. 17. Fass R, Hell R, Garewal H, Martinez P, Pulliam G, Wendel C, Sampliner RI. Correlation of oesophageal acid exposure with Barrett’s oesophagus length. Gut 2001;48:310-3. 18. Rex D, Cummings O, Shaw M, Cummings M, Wong R, Vasudeva R, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:167077.